|
TWI235059B
|
|
Salts of keto acids and amine derivatives, and their use for the treatment of pathological conditions involving silent neurons
|
|
AU8867998A
|
|
Benzamide cycloalkyl stimulating high and low gastrointestinal motricity
|
|
ZA9806633B
|
|
Benzamide derivatives which stimulate upper and lower gastrointestinal motoricity
|
|
AU7534698A
|
|
Amino acid derivatives inhibiting extracellular matrix metalloproteinase and tnfalpha release
|
|
EP0833634A1
|
|
Use of n-cyclohexyl benzamides for treating bowel disorders
|
|
EP0692249A1
|
|
Compounds bearing one or more oxime functions, stabilized in aqueous solution, process to prepare them, and their use as drugs
|
|
FR2731619A1
|
|
PHARMACEUTICAL COMPOSITIONS CONTAINING L-ETRABAMINE, USES THEREOF AND PREPARATION METHODS
|
|
US5273983A
|
|
Cyclohexylbenzamide derivatives, their preparations and their use as gastrointestinal stimulants
|
|
EP0117771A1
|
|
Imino-2 pyrrolidines, process for their preparation and their therapeutical use
|
|
EP0021940A1
|
|
Amino derivatives of benzothiazole, process for their preparation and their use in therapy
|
|
EP0015171A1
|
|
Condensed derivatives of pyrrolidine or piperidine, process for their preparation and composition containing them
|
|
FI794062A
|
|
Fruit processing for therapeutic therapy 4- (2-benzofuryl) -1-pyrrolinderivat
|
|
DK546979A
|
|
Analogy procedure for preparing unknown unknown 4- (2-benzofuryl) -1-pyrroline derivatives
|
|
IE49024B1
|
|
New benzofuran derivatives, process for their preparation and their therapeutic applications
|
|
AU5389479A
|
|
Benzofuizan derivatives
|
|
CA1109469A
|
|
Benzofuran derivatives, process for their preparation and their therapeutic applications
|
|
EP0007824A1
|
|
Benzofurane derivatives, process for their preparation and therapeutic composition containing them.
|
|
US4181736A
|
|
Phenylacetic acid derivatives and therapeutic composition containing same
|
|
GB2007232A
|
|
Benzo thiazole derivatives process for their preparation and their thereapeutic applications
|
|
GB1550496A
|
|
1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications
|
